Digital Pharmacy Retail in Austria: Key Statistics and Outlook 2026

The Austrian pharmaceutical retail landscape is undergoing a structured digital transformation. This analysis provides a data-driven overview of the online pharmacy market in Austria, detailing its current state and projections through 2026. Key metrics, growth trajectories, and regulatory factors are presented to contextualize this evolving sector within the DACH region.

Market Size and Growth Projections to 2026

The digital pharmacy retail market in Austria, primarily encompassing over-the-counter (OTC) medications, health products, dietary supplements, and beauty items, demonstrates consistent growth. Sales of prescription-only (rezeptpflichtige) medications online are subject to strict regulatory limitations within Austria, thus limiting their inclusion in the direct Austrian online pharmacy market size. Cross-border sales from other EU member states for non-prescription items contribute significantly to the overall digital retail volume.

The market’s expansion is driven by increasing consumer digital adoption, convenience, and a broader product selection compared to traditional brick-and-mortar pharmacies. QuantisIntel data indicates a robust compound annual growth rate (CAGR) for the sector.

Source: QuantisIntel Market Analysis, 2024

In 2023, the digital pharmacy retail market for OTC, health, and beauty products in Austria reached an estimated €152.5 million. Projections indicate this market segment will expand to approximately €247.0 million by 2026, representing a CAGR of 17.5% over the three-year period. This growth rate significantly outpaces the overall retail sector and the traditional pharmacy segment.

The online penetration within the total Austrian OTC market stood at 9.2% in 2023. This figure is forecast to reach 14.8% by 2026, illustrating a sustained shift in consumer purchasing channels for non-prescription health items. The average order value (AOV) for digital pharmacy purchases is also projected to increase moderately from €58.20 in 2023 to €63.50 by 2026, reflecting a slight upward trend in basket size. The number of online transactions is expected to rise from 2.6 million in 2023 to 3.9 million by 2026, indicating increased transaction frequency alongside market value growth.

Key Market Participants and Structure

The Austrian digital pharmacy market is characterized by a dual structure: domestic online offerings from established Austrian Apotheken and drugstores, and significant cross-border activity from larger German online pharmacies. The regulatory environment in Austria, particularly concerning prescription drugs, shapes the competitive landscape.

Major players facilitating online sales into Austria include established German e-pharmacies, which benefit from a more liberal regulatory framework in their home market regarding distance selling of OTC products. These entities often leverage scale and logistics networks to serve Austrian consumers. Domestic Austrian pharmacies and drugstore chains also operate online platforms, typically focusing on their permitted product ranges and often integrating click-and-collect services.

The market share distribution for digital sales of OTC and health products in Austria in 2023 indicated the following approximate breakdown:

• German-based online pharmacies: Approximately 45-50%
  • This segment includes players such as Shop Apotheke Europe and DocMorris (via its Europa Apotheek Venlo subsidiary), which are prominent due to their broad assortments and established e-commerce operations.
• Austrian online pharmacies and drugstore chains: Approximately 30-35%
  • This segment comprises online shops operated by individual Austrian Apotheken, pharmacy cooperatives, and larger drugstore chains that feature health and wellness product sections.
• Other online retailers (e.g., marketplaces, specialized health stores): Approximately 15-20%
  • This category includes general e-commerce platforms and niche online retailers offering health-related products that do not fall under strict pharmacy regulations.

No single player holds a dominant majority, with the market showing fragmentation among domestic providers and competition from cross-border entities. The landscape is influenced by brand recognition, pricing strategies, and logistics capabilities.

Consumer Adoption and Purchasing Trends

Austrian consumers are increasingly integrating digital channels into their health and wellness purchasing habits. Data from 2023 indicates specific demographic and behavioral trends driving this adoption.

• Demographic Penetration:

  • Age Group 25-44: Online pharmacy usage stands at approximately 41%, representing the highest adoption rate among all age groups. This segment values convenience and digital proficiency.
  • Age Group 45-64: Adoption is around 32%, indicating a growing comfort level with online purchasing for health products among older demographics.
  • Age Group 18-24: Penetration is approximately 28%, often driven by specific product needs (e.g., cosmetics, dietary supplements) and high general e-commerce engagement.
  • Age Group 65+: Adoption is lower, estimated at 15%, but shows a gradual increase as digital literacy improves across the population.

• Product Categories:

  • The most frequently purchased categories online include pain relief medications, cold and flu remedies, vitamins and dietary supplements, and dermatology products. These categories align with self-medication trends and routine health maintenance.
  • Cosmetics and personal care items available through pharmacy channels also exhibit strong online sales performance.

• Motivation for Online Purchase:

  • Convenience: 68% of online pharmacy users cite convenience (24/7 availability, home delivery) as a primary motivator.
  • Price: 55% indicate competitive pricing as a key factor, particularly for branded OTC products.
  • Product Range: 47% value the broader selection of products available online compared to typical local pharmacies.
  • Privacy: A smaller segment (18%) prefers online purchasing for privacy reasons related to certain health conditions.

The average purchase frequency for Austrian online pharmacy users is estimated at 3.5 times per year. This suggests a pattern of recurring purchases for staple health products rather than sporadic, urgent needs.

Regulatory Framework and Market Impact

The regulatory environment significantly shapes the operational scope and growth potential of digital pharmacy retail in Austria. The Austrian Apothekengesetz (Pharmacy Act) and related regulations govern the dispensing of medications.

• Prescription Medications (rezeptpflichtige Arzneimittel): The direct online sale and shipment of prescription medications by Austrian pharmacies to consumers are not permitted. This restriction maintains the traditional role of local pharmacies in dispensing such drugs, requiring a physical visit and pharmacist consultation. This regulatory stance substantially limits the addressable market for domestic online pharmacies to OTC and non-pharmaceutical health products.
• Over-the-Counter (OTC) Medications: Austrian pharmacies are permitted to sell OTC medications online. However, many operate with a focus on local delivery or click-and-collect models, rather than extensive national shipping operations comparable to larger e-pharmacies in other EU states.
• Cross-Border Sales: Under the principle of free movement of goods within the European Union, online pharmacies based in other EU countries (e.g., Germany) are generally allowed to ship OTC medications to Austrian consumers. This legal framework has enabled major German online pharmacies to establish a significant presence in the Austrian market for non-prescription items.
• Supervision: The Österreichische Apothekerkammer (Austrian Chamber of Pharmacists) oversees the professional conduct of pharmacies and pharmacists, including online operations. Compliance with data protection regulations (DSGVO/GDPR) and consumer protection laws is mandatory for all online retailers operating in Austria, irrespective of their country of origin.
• MwSt. (Value Added Tax): Digital pharmacy products are subject to Austrian MwSt. rates, typically 10% for medicines and certain health products, and 20% for other items like cosmetics or general health supplements, depending on their classification.

The restrictive stance on prescription drug e-commerce ensures that the digital pharmacy market in Austria will continue to be predominantly driven by OTC and related health product sales through 2026. Any significant shift in market composition would necessitate a fundamental change in Austrian pharmaceutical legislation.

Frequently Asked Questions

What is the projected market size for digital pharmacy retail in Austria by 2026? The Austrian digital pharmacy retail market, encompassing OTC, health, and beauty products, is projected to reach €247.0 million by 2026. This signifies a Compound Annual Growth Rate (CAGR) of 17.5% from its 2023 value of €152.5 million.

What is the forecast online penetration of the Austrian OTC market by 2026? By 2026, the online penetration within the total Austrian OTC market is forecast to reach 14.8%. This represents a notable increase from 9.2% in 2023, reflecting a continued shift in consumer purchasing behavior.

Can prescription medications be purchased online in Austria? No, the direct online sale and shipment of prescription-only (rezeptpflichtige) medications by Austrian pharmacies to consumers are not permitted. This regulatory stance restricts the domestic digital pharmacy market predominantly to OTC and non-pharmaceutical health products.

Which entities hold the largest market share in the Austrian digital pharmacy retail sector? German-based online pharmacies account for approximately 45-50% of digital sales of OTC and health products into Austria. Austrian online pharmacies and drugstore chains hold about 30-35%, with other online retailers comprising the remaining 15-20%.

For deeper strategic analysis, see our full report.

The Austrian digital pharmacy retail market, focused on OTC, health, and beauty products, is projected to reach €247.0 million by 2026, demonstrating a robust 17.5% CAGR. This expansion is largely influenced by cross-border online pharmacies and increasing consumer digital adoption, while the regulatory framework continues to restrict the online sale of prescription medications.